Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-039239)

Filing Details

Accession Number:: 0001209191-17-039239
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-12 17:29:14
Reporting Period:: 2017-06-08

Filing Date:: 2017-06-12
Accepted Time:: 2017-06-12 17:29:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604464	Atara Biotherapeutics Inc.	ATRA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1329959	Giltner Carol Gallagher	C/O Atara Biotherapeutics, Inc. 611 Gateway Boulevard, Suite 900 South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-08	5,000	$0.00	108,374	No	4	A	Direct
Common Stock	Disposition	2017-06-09	1,000	$13.15	107,374	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (Right to Buy)	Acquisiton	2017-06-08	21,500	$0.00	21,500	$13.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,500		2027-06-08	No	4	A	Direct

Footnotes

These restricted stock units shall vest on June 8, 2018, subject to the Reporting Person's continuous service.
Transaction pursuant to Rule 10b5-1 Plan adopted October 14, 2016.
The option shall vest on June 8, 2018, subject to the Reporting Person's continuous service.